Home › Funds › Sofinnova Investments, Inc. › GILD

Sofinnova Investments, Inc. position in GILD

GILEAD SCIENCES INC · Health Care

Sofinnova Investments, Inc. reported holding 343,100 shares of GILD (GILEAD SCIENCES INC) in its Q2 2026 13F filing — a position valued at US$43.3M, representing 2.31% of its reported portfolio and ranking #12 among its reported holdings. Sofinnova Investments, Inc. has disclosed GILD holdings in 5 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)343.10K sh
Reported value held$43.35M
Portfolio Weight2.31%
First reportedQ4 2024
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sofinnova Investments, Inc.'s GILD position evolved

Sofinnova Investments, Inc. first disclosed a stake in GILD in Q4 2024 at 774,227 shares (US$71.5M). The position peaked in Q3 2025 at 1,252,312 shares, worth US$139.0M. Across 5 filings, Sofinnova Investments, Inc. increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 343,100 shares valued at US$43.3M. Notable position changes include a 46% trim in Q1 2025 (shares were roughly flat over the following quarter), a 151% increase in Q2 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 774.23K $71.52M New
Q1 2025 418.90K $46.94M Reduce
Q2 2025 1.05M $116.45M Add
Q3 2025 1.25M $139.01M Add
Q2 2026 343.10K $43.35M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Sofinnova Investments, Inc. held GILD?

Sofinnova Investments, Inc. has disclosed GILD holdings in 5 of the last 7 reported quarters, going back to Q4 2024.

What is Sofinnova Investments, Inc.'s current position in GILD?

As of Q2 2026, Sofinnova Investments, Inc. holds 343.10K shares of GILD (GILEAD SCIENCES INC), valued at $43.35M, representing 2.31% of its reported portfolio and ranking #12.

Has Sofinnova Investments, Inc. been buying or selling GILD?

In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. newly opened its position in GILD. The position peaked in Q3 2025 at 1.25M shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.